JPMorgan Chase & Co., one of the largest financial institutions in the world, has become a substantial shareholder in Cochlear Ltd. The bank's holding gives it 5.51% voting power in the Australian-based hearing implant manufacturer.
This development comes after JPMorgan Chase & Co. acquired 8.3 million shares in Cochlear Ltd, according to publicly available information. The exact value of the investment is not disclosed.
More on Stocks
Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.
Market sentiment intelligence for apps, funds & agents
Location
729 55 Ave SW
Calgary AB T2V 0G4
Canada
© 2026 Guavy Inc
